<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03199482</url>
  </required_header>
  <id_info>
    <org_study_id>kinda</org_study_id>
    <nct_id>NCT03199482</nct_id>
  </id_info>
  <brief_title>Effect of Pretreatment Dexamethazone on Pain and Success of Nerve Block</brief_title>
  <official_title>A Comparative Evaluation of Effect of Dexamethazone on Postendodontic Pain and Success of Inferior Alveolar Nerve Block in Mandibular Molars With Symptomatic Irreversible Pulpitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Comparative Evaluation of the effect of pretreatment dexamethasone versus placebo on&#xD;
      post-endodontic pain and success of inferior alveolar nerve block in Mandibular molars with&#xD;
      symptomatic Irreversible Pulpitis: A Blinded Randomized Clinical Trial Therapeutic study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants, Interventions and Outcome&#xD;
&#xD;
      Setting:&#xD;
&#xD;
      Patients are of the clinic of endodontics at the faculty of oral and dental medicine, Cairo&#xD;
      University, Urban area, Cairo governorate, Egypt.&#xD;
&#xD;
        -  The dental Unit is Adec 200 U.S.A.&#xD;
&#xD;
        -  The x-ray Machine is ViVi, S.r.I, Italy&#xD;
&#xD;
        -  The x-ray films are Kodac, speed D, size 2.&#xD;
&#xD;
        -  The operators are master degree students in the department of Endodontics.&#xD;
&#xD;
        -  No dental assistant&#xD;
&#xD;
        -  Time: 2017-2016&#xD;
&#xD;
      Procedure steps:&#xD;
&#xD;
        1. Patients are asked to rate the pain level on numerical rating scale before the&#xD;
           administration of drug to get the baseline record for the pain preoperatively.&#xD;
&#xD;
        2. Thirty minutes before the endodontic procedure,dexamethasone (0.5 mg) or a placebo will&#xD;
           be administered.Root canal therapy in all cases was completed in a single visit.&#xD;
&#xD;
        3. After explanation of the treatment procedures (according to individual needs), the tooth&#xD;
           will be anesthetized by an inferior alveolar nerve block (1.8 ml mepivacaine&#xD;
           hydrochloride 2% 1: 100,000 epinephrine) using a side loading aspirating syringe and&#xD;
           27-gauge long needle.&#xD;
&#xD;
        4. At 15-minutes post injection, access cavity will be performed using round bur size 4 and&#xD;
           endo-z bur and the pain is recorded .&#xD;
&#xD;
        5. Tooth is then isolated using rubber dam to prevent introduction of saliva and Bactria&#xD;
           from the oral cavity.&#xD;
&#xD;
        6. Checking the patency of the canal with K- file size 10 taper 0.02, extirpation of pulp&#xD;
           with H-file size 15 taper 0.02 with recording the pain.&#xD;
&#xD;
        7. Cleaning and shaping will be performed with a hybrid technique using hand K-files and&#xD;
           rotary files for all teeth.&#xD;
&#xD;
        8. Irrigation will be performed with 2.5% NaOCl after each instrument in all cases. At the&#xD;
           end of instrumentation, the final irrigation will made by saline.&#xD;
&#xD;
        9. After drying the canals with sterile paper points, they will be coated with AD-Seal&#xD;
           sealer and obturated with gutta-percha using the lateral condensation technique.&#xD;
&#xD;
       10. The tooth will be then temporized by using cavit temporary filling and reduced from&#xD;
           occlusion.&#xD;
&#xD;
       11. A rescue medication (ibuprofen) will be prescribed and the patients will be instructed&#xD;
           to take it only if they experienced severe pain postoperatively. If rescue medication&#xD;
           will be taken within the 48 hours after the treatment, then the patient will be excluded&#xD;
           from the study.&#xD;
&#xD;
      Patients will be asked to make a mark on the point that represents level of perceived pain.&#xD;
      (before the commencement of any treatment [baseline score]; at access and pulp extirpation,&#xD;
      immediately after treatment completion; and 6, 12, 24, and 48 hours after the commencement of&#xD;
      treatment). All subjects will be recalled after 2 days to return the pain diary and for a&#xD;
      clinical evaluation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">July 12, 2017</start_date>
  <completion_date type="Anticipated">July 7, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 12, 2017</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>dexamethazone</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>investigator</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>48 hours</time_frame>
    <description>Numerical rating scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>success of inferior alveolar nerve block</measure>
    <time_frame>2 hours</time_frame>
    <description>Numerical rating scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Drug dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>preoperative single dose of dexamethasone 0.5 mg oral tablet given to patients before starting of root canal treatment by 30 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo will be administrated to patients before stating of root canal treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone Oral Tablet</intervention_name>
    <description>single dose of tablet 0.5 mg dexamethasone given to patients before starting of root canal treatment by 30 minutes or placebo</description>
    <arm_group_label>Drug dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo will be administrated 30 minutes before start of root canal treatment</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients in good health with no systemic disease (American Society of&#xD;
             Anesthesiologists Class II)&#xD;
&#xD;
          2. Patients having symptomatic irreversible pulpitis in one of their mandibular molars&#xD;
&#xD;
          3. Age range is between 20 and 50 years&#xD;
&#xD;
          4. Patients who can understand the categorical tool (points) for measurement&#xD;
&#xD;
          5. Patients able to sign informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with positive percussion test&#xD;
&#xD;
          2. Patients having history of necrosis with or without apical pathosis&#xD;
&#xD;
          3. Patients have sinus tract or fistula extraoral or intraoral&#xD;
&#xD;
          4. Patients having active pain in more than one molar&#xD;
&#xD;
          5. Patients who had taken analgesics in the 12 hours preceding the preparation.&#xD;
&#xD;
          6. Complicating systemic disease&#xD;
&#xD;
          7. Subjects with allergies and hypersensitivity to or unable to take dexamethasone&#xD;
&#xD;
          8. Teeth with grade 2 or 3 mobility&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manar Hamouda, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>mai M sayed, bachelore</last_name>
    <phone>01012232932</phone>
    <phone_ext>2012</phone_ext>
    <email>mai.safei247@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>amr M mansy, bachelore</last_name>
    <phone>01111663611</phone>
    <phone_ext>2012</phone_ext>
    <email>dr.amr.mansy.12@outlook.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of Dentistry</name>
      <address>
        <city>Cairo</city>
        <state>Manyal</state>
        <zip>02</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>mai mohamed safei eldin, bachelore</last_name>
      <phone>0102232932</phone>
      <phone_ext>2012</phone_ext>
      <email>mai.safei247@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>June 18, 2017</study_first_submitted>
  <study_first_submitted_qc>June 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2017</study_first_posted>
  <last_update_submitted>June 23, 2017</last_update_submitted>
  <last_update_submitted_qc>June 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mai Mohamed Safei Eldin Sayed</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

